{"title":"Quality of life through therapeutic advances. Pharmaceutical company news: Ipsen N.V.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>IPSEN is the Belgian subsidiary of the independent European pharmaceutical company Beaufour Ipsen, founded in 1929 by Dr. Henri Beaufour. With an expanding international presence, the group invests almost 20% of group turnover in research and development of high technology ethical products. Beaufour Ipsen R & D's fundamental goal is quality of life for patients with a special emphasis on homeostatic regulation, achieving the optimal efficacy versus tolerance ratio.</p>","PeriodicalId":75424,"journal":{"name":"Acta urologica Belgica","volume":"66 2","pages":"21-2"},"PeriodicalIF":0.0000,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta urologica Belgica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
IPSEN is the Belgian subsidiary of the independent European pharmaceutical company Beaufour Ipsen, founded in 1929 by Dr. Henri Beaufour. With an expanding international presence, the group invests almost 20% of group turnover in research and development of high technology ethical products. Beaufour Ipsen R & D's fundamental goal is quality of life for patients with a special emphasis on homeostatic regulation, achieving the optimal efficacy versus tolerance ratio.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
